In Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33(+) Acute Myeloid Leukemia

por Dutour, A., Marin, V., Pizzitola, I., Valsesia-Wittmann, S., Lee, D., Yvon, E., Finney, H., Lawson, A., Brenner, M., Biondi, A., Biagi, E., Rousseau, R.
Publicado 2012

Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy.

por King, D. J., Antoniw, P., Owens, R. J., Adair, J. R., Haines, A. M., Farnsworth, A. P., Finney, H., Lawson, A. D., Lyons, A., Baker, T. S.
Publicado 1995